Flunixin Meglumine Injectable Solution (Im, Iv) 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable solution (IM, IV)

Available Strengths: 100 mg/mL

Reference Brands: Banamine (US)

Category: Veterinary Product

Flunixin Meglumine injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes, reducing prostaglandin synthesis. It effectively relieves pain, inflammation, and fever in animals. Benefits include rapid pain relief, decreased inflammation, and improved comfort in livestock and horses, supporting animal health and productivity.

Product Description:

Flunixin Meglumine injection is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in line with GMP and IVDR standards. In the US, FDA approval involves comprehensive clinical data and safety evaluations, mainly for pain and inflammation in horses, livestock, and pigs. In the EU, CE marking certifies conformity with veterinary medicinal regulations. These products undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective flunixin meglumine formulations worldwide.